Our findings from the retrospective evaluation at the breast unit of PSCUH suggested that platinum-based neoadjuvant chemotherapy was highly effective in breast cancer patients with BRCA1 gene mutations. The gene discussed is BRCA1; the disease is breast carcinoma.